Postmarketing surveillance study of tocilizumab in Japanese patients with rheumatoid arthritis

Trial Profile

Postmarketing surveillance study of tocilizumab in Japanese patients with rheumatoid arthritis

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2015

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 13 Jun 2015 Results of 3-year extension study in 5573 patients presented at the 16th Annual Congress of the European League Against Rheumatism.
    • 11 Nov 2011 New trial record
    • 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top